We are live on ! Find out more
WKWM

Walter & Keenan Wealth Management Portfolio holdings

AUM $355M
1-Year Est. Return 23.15%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+23.15%
3 Year Est. Return
+79.94%
5 Year Est. Return
+94%
10 Year Est. Return
+298.49%
AUM
$188M
AUM Growth
+$6.82M
Cap. Flow
+$42.3M
Cap. Flow %
22.5%
Top 10 Hldgs %
32.83%
Holding
149
New
10
Increased
42
Reduced
41
Closed
7

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$7.78M
2
WFC icon
Wells Fargo
WFC
+$950K
3
WMT icon
Walmart Inc
WMT
+$815K
4
VOD icon
Vodafone
VOD
+$766K
5
CVS icon
CVS Health
CVS
+$728K

Sector Composition

Rank Sector Weight
1 Financials 15.19%
2 Healthcare 14.1%
3 Technology 13.3%
4 Industrials 11.18%
5 Energy 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$132B
$538K 0.29%
9,214
+464
+5% +$25.4K
EFX icon
77
Equifax
EFX
$21.4B
$531K 0.28%
4,490
SRCE icon
78
1st Source
SRCE
$2.12B
$518K 0.28%
11,569
-5,547
-32% -$214K
WBA
79
DELISTED
Walgreens Boots Alliance
WBA
$513K 0.27%
6,200
DD
80
DELISTED
Du Pont De Nemours E I
DD
$496K 0.26%
6,761
AGN
81
DELISTED
Allergan plc
AGN
$494K 0.26%
2,350
+100
+4% +$20.7K
MMU
82
Western Asset Managed Municipals Fund
MMU
$554M
$486K 0.26%
35,400
BP icon
83
BP
BP
$107B
$482K 0.26%
15,044
+3,751
+33% +$113K
BBN icon
84
BlackRock Taxable Municipal Bond Trust
BBN
$986M
$480K 0.26%
22,200
TXN icon
85
Texas Instruments
TXN
$261B
$474K 0.25%
6,499
AMGN icon
86
Amgen
AMGN
$222B
$468K 0.25%
3,200
+600
+23% +$90.3K
IAT icon
87
iShares US Regional Banks ETF
IAT
$681M
$454K 0.24%
+10,000
New +$405K
RDS.A
88
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$440K 0.23%
8,386
-1,546
-16% -$76.9K
HTUS icon
89
Hull Tactical US ETF
HTUS
$163M
$438K 0.23%
17,000
+4,000
+31% +$106K
OKS
90
DELISTED
Oneok Partners LP
OKS
$430K 0.23%
10,000
DEM icon
91
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$423K 0.23%
11,327
-500
-4% -$18.7K
FUN icon
92
Cedar Fair
FUN
$1.67B
$417K 0.22%
6,500
CTS icon
93
CTS Corp
CTS
$1.89B
$403K 0.21%
18,000
-2,000
-10% -$40.9K
SPLK
94
DELISTED
Splunk Inc
SPLK
$399K 0.21%
7,800
-300
-4% -$17.3K
AMTD
95
DELISTED
TD Ameritrade Holding Corp
AMTD
$392K 0.21%
8,999
CSX icon
96
CSX Corp
CSX
$93.1B
$363K 0.19%
30,300
+1,302
+4% +$14.6K
DUK icon
97
Duke Energy
DUK
$97.3B
$363K 0.19%
4,674
-266
-5% -$20.4K
CERN
98
DELISTED
Cerner Corp
CERN
$355K 0.19%
7,500
-9,000
-55% -$478K
KMI icon
99
Kinder Morgan
KMI
$68.7B
$354K 0.19%
17,086
-2,074
-11% -$43.8K
LMT icon
100
Lockheed Martin
LMT
$136B
$349K 0.19%
1,396
-100
-7% -$25K

Similar funds

Walter & Keenan Wealth Management's Q4 2016 Portfolio in Review

As of Q4 2016, Walter & Keenan Wealth Management held 149 positions worth $188M, up 3.8% from $181M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Walter & Keenan Wealth Management deployed $42.3M of net new capital in Q4 2016, opening 10 new positions and adding to 42 existing holdings. Its largest new stake was Schwab US Broad Market ETF: 181,008 shares worth $1.64M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Philip Morris, an estimated $7.78M trimmed.

  • Walter & Keenan Wealth Management's largest Q4 2016 buy was Schwab US Broad Market ETF: 181,008 shares worth $1.64M.
  • Walter & Keenan Wealth Management added most to Berkshire Hathaway Class A in Q4 2016, an estimated $46.2M increase.
  • Walter & Keenan Wealth Management's biggest Q4 2016 reduction was Philip Morris, cutting an estimated $7.78M.
  • Walter & Keenan Wealth Management fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $561K.
  • Walter & Keenan Wealth Management's ten largest holdings make up 33% of its $188M portfolio in Q4 2016.
  • Walter & Keenan Wealth Management opened 10 new positions and closed 7 in Q4 2016.
  • Walter & Keenan Wealth Management's portfolio value rose 3.8% quarter-over-quarter to $188M.

Based on Walter & Keenan Wealth Management's 13F filing for Q4 2016, filed 2 Feb 2017.